Inventor of 4-disease drug gets a boost thanks to ISRAEL21c
ISRAEL21c article on David Naor’s peptide drew a $5k investment and many reader inquiries. An Israeli biotech company is planning clinical studies.
ISRAEL21c article on David Naor’s peptide drew a $5k investment and many reader inquiries. An Israeli biotech company is planning clinical studies.
A special peptide under development in Israel declares war against chronic inflammatory and neurodegenerative diseases.